Related Experiment Video
Updated: Dec 20, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Progression-Dependent Altered Metabolism in Osteosarcoma Resulting in Different Nutrient Source Dependencies.
Raphaela Fritsche-Guenther1,2, Yoann Gloaguen1,2,3, Marieluise Kirchner2,4
1Berlin Institute of Health Metabolomics Platform, Berlin Institute of Health (BIH), 13125 Berlin, Germany.
Metabolic changes in osteosarcoma (OS) cells drive metastasis. Inhibiting key metabolic pathways like glycolysis and glutaminolysis reduced cancer cell proliferation, suggesting new therapeutic targets for lung metastases.
Area of Science:
- Oncology
- Metabolomics
- Cancer Biology
Background:
- Osteosarcoma (OS) is a primary bone cancer with frequent lung metastasis.
- Understanding OS metastatic processes is crucial for effective treatment development.
- Metabolic alterations are key to cancer progression and can inform prognosis.
Purpose of the Study:
- To identify metabolic alterations during osteosarcoma progression and metastasis.
- To investigate the role of glycolysis and glutaminolysis in OS cell proliferation and energy metabolism.
- To explore potential sex-dependent metabolic differences in OS lung metastases.
Main Methods:
- Targeted gas chromatography-mass spectrometry (GC-MS) was used to analyze metabolic profiles.
- In vitro studies utilized a female OS cell line model representing benign, malignant, and metastatic stages.
- In vivo analysis explored metabolic differences in patient-derived lung metastases.
Main Results:
- Metastatic OS cells exhibited increased energy metabolism and faster metabolic flux compared to malignant cells.
- Inhibition of glycolysis and glutaminolysis reduced proliferation in metastatic OS cells.
- Malignant, non-metastatic OS cells were resistant to glycolytic inhibition but dependent on glutamine.
- Female lung metastasis (LM) patients showed decreased central carbon metabolism compared to male LM patients.
Conclusions:
- Metabolic reprogramming, particularly glycolysis and glutaminolysis, is critical for OS metastasis.
- Targeting these metabolic pathways may offer therapeutic strategies for OS lung metastases.
- Evidence suggests sex-dependent metabolic alterations in OS lung metastases warrant further investigation.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Osteoclasts in Bone Remodeling

